{"timestamp": 1771603690.3291223, "value": {"ticker": "NAGE", "company_name": "Niagen Bioscience, Inc.", "short_name": "Niagen Bioscience, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 389852992, "float_shares": 52706662, "shares_outstanding": 79806139, "short_ratio": 7.28, "short_percent_of_float": 0.1125, "shares_short": 5935773, "shares_short_prior": 5674234, "insider_percent_held": 0.34002, "institution_percent_held": 0.41799998, "total_cash": 64138000, "total_debt": 3055000, "total_revenue": 124709000, "revenue_growth": 0.329, "earnings_growth": 1.5, "profit_margins": 0.16381, "gross_margins": 0.63894004, "operating_margins": 0.124639995, "debt_to_equity": 4.323, "current_ratio": 4.122, "book_value": 0.884, "price_to_book": 5.526018, "operating_cashflow": 21408000, "free_cashflow": 13786000, "price": 4.885, "52w_high": 14.69, "52w_low": 4.84, "avg_volume": 807055, "avg_volume_10d": 914230, "full_time_employees": 104, "audit_risk": 5, "overall_risk": 4}}